WEKO3
アイテム
Synthesis and preliminary evaluation of 18F-labeled 1-(6,7-dimethyl-4-(methylamino)-1,3-dihydro-2H-pyrrolo[3,4-c]pyridin-2-yl)-2-(trans-2-(6-fluoropyridin-3-yl)cyclopropyl)ethan-1-one for imaging muscarinic acetylcholine receptor subtype 4
https://repo.qst.go.jp/records/80110
https://repo.qst.go.jp/records/80110e1d9a17c-88e0-42b0-beb1-0d10b46bf5d8
Item type | 学術雑誌論文 / Journal Article(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2020-06-24 | |||||
タイトル | ||||||
タイトル | Synthesis and preliminary evaluation of 18F-labeled 1-(6,7-dimethyl-4-(methylamino)-1,3-dihydro-2H-pyrrolo[3,4-c]pyridin-2-yl)-2-(trans-2-(6-fluoropyridin-3-yl)cyclopropyl)ethan-1-one for imaging muscarinic acetylcholine receptor subtype 4 | |||||
言語 | ||||||
言語 | eng | |||||
資源タイプ | ||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_6501 | |||||
資源タイプ | journal article | |||||
アクセス権 | ||||||
アクセス権 | metadata only access | |||||
アクセス権URI | http://purl.org/coar/access_right/c_14cb | |||||
著者 |
Deng, Xiaoyun
× Deng, Xiaoyun× Zhang, Yiding× Rong, Jian× Kumata, Katsushi× Shao, Tuo× Wang, Gangqiang× Hatori, Akiko× Mori, Wakana× Yu, Qingzhen× Kuan, Hu× Fujinaga, Masayuki× Shao, Yihan× Josephson, Lee× Sun, Shaofa× Ming-Rong, Zhang× Liang, Huan× Zhang, Yiding× Kumata, Katsushi× Hatori, Akiko× Mori, Wakana× Kuan, Hu× Fujinaga, Masayuki× Ming-Rong, Zhang× Liang, Huan |
|||||
抄録 | ||||||
内容記述タイプ | Abstract | |||||
内容記述 | Positive allosteric modulators of muscarinic acetylcholine receptor subtype 4 have been identified as promising activators for the treatment of neurological disorders and neurodegenerative diseases, including schizophrenia, Alzheimer's disease (AD) and dementia with Lewy bodies (DLB). Herein we report the synthesis and preliminary evaluation of a 18F-labeled positron emission tomography ligand based on a M4 activator (7). 18F-Isotopologue of 7 was prepared in a reasonable radiochemical yield with high radiochemical purity (>99%) and high molar activity (>37 GBq/µmol). In vitro autoradiography studies indicated that the ligand possessed moderate in vitro specific binding. Dynamic PET studies in vivo demonstrated that [18F]7 (also named as [18F]M4R-1911) failed to cross the blood–brain barrier. Therefore, further chemical scaffold optimization in chemotype of 7 is necessary to overcome limited brain permeability and improve specific binding. | |||||
書誌情報 |
Tetrahedron Letters 巻 61, 号 27, 発行日 2020-05 |
|||||
出版者 | ||||||
出版者 | Elsevier | |||||
ISSN | ||||||
収録物識別子タイプ | ISSN | |||||
収録物識別子 | 0040-4039 | |||||
DOI | ||||||
識別子タイプ | DOI | |||||
関連識別子 | 10.1016/j.tetlet.2020.152060 | |||||
関連サイト | ||||||
識別子タイプ | URI | |||||
関連識別子 | https://www.sciencedirect.com/science/article/pii/S0040403920305062 |